These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2999840)

  • 1. Acebutolol-induced decrease of mononuclear leukocyte beta-adrenoceptors in hypertension.
    Basso A; Piantanelli L; Cognini G; Giunta S; Andreoni A; Paciaroni E
    Pharmacology; 1985; 31(5):278-83. PubMed ID: 2999840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atenolol-induced regulation of leukocyte beta 2-adrenoceptors in hypertension.
    Piantanelli L; Giunta S; Basso A; Cognini G; Andreoni A; Paciaroni E
    Pharmacology; 1984; 29(4):210-4. PubMed ID: 6093157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of acebutolol, a cardioselective beta-adrenoceptor blocking agent, on the blood pressure in rats (author's transl)].
    Takami N; Sugawara K; Ozaki M
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):747-54. PubMed ID: 44260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of beta-adrenergic blockade on short-term variability of blood pressure and heart rate in essential hypertension.
    Girard A; Meilhac B; Mounier-Vehier C; Elghozi JL
    Clin Exp Hypertens; 1995; 17(1-2):15-27. PubMed ID: 7735265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid identification of patients with essential hypertension sensitive to acebutolol (a new cardioselective beta-blocker).
    Menard J; Bertagna X; N'Guyen PT; Degoulet P; Corvol P
    Am J Med; 1976 May; 60(6):886-90. PubMed ID: 14503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of the alpha 1-receptor blocker prazosin and the beta 1-receptor blocker acebutolol and their combination on blood pressure and pressure rate product. Ergometric studies of hypertensive patients].
    Franz IW
    Z Kardiol; 1984 Jan; 73(1):21-8. PubMed ID: 6367245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acebutolol test in moderate arterial hypertension. Action on systolic time intervals].
    Ducrocq MB; Degoulet P; Charpentier A; Corvol P; Ménard J
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3268-72. PubMed ID: 768908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of acebutolol and propranolol in hypertensive patients during exercise.
    Reim HG; Wagner W
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):238-43. PubMed ID: 4008112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the beta 1 and beta 2 adrenoceptor blocking properties of acebutolol and propranolol.
    Whitsett TL; Levin DC; Manion CV
    Chest; 1982 Dec; 82(6):668-73. PubMed ID: 6128186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of arterial hypertension with acebutolol. Double-blind study with placebos].
    Letac B; Fillastre JP; Wolf LM; Safar M
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3273-7. PubMed ID: 1219635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and long-term effects of acebutolol on systemic and renal hemodynamics, body fluid volumes, catecholamines, active renin, aldosterone, and lymphocyte beta-adrenoceptor density.
    van den Meiracker AH; Man in 't Veld AJ; Fischberg DJ; Molinoff PB; van Eck HJ; Boomsma F; Derkx FH; Schalekamp MA
    J Cardiovasc Pharmacol; 1988 Apr; 11(4):413-23. PubMed ID: 2453744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of acebutolol on the renin-aldosterone system in essential arterial hypertension].
    Plouin PF; Ménard J; Corvol P
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3234-8. PubMed ID: 1219630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of intrinsic sympathomimetic activity for beta blockers.
    Jaillon P
    Am J Cardiol; 1990 Sep; 66(9):21C-23C. PubMed ID: 1977302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacology of acebutolol in animals].
    Basil B
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3217-21. PubMed ID: 1219628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic significance of dosing intervals in beta receptor blocking therapy of hypertension with acebutolol.
    Frick MH; Kala R
    Am J Cardiol; 1981 Nov; 48(5):911-6. PubMed ID: 6118059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled trial of acebutolol in hypertension.
    Hansson L; Berglund G; Andersson O; Holm M
    Eur J Clin Pharmacol; 1977 Oct; 12(2):89-92. PubMed ID: 336378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.
    Singh BN; Thoden WR; Ward A
    Drugs; 1985 Jun; 29(6):531-69. PubMed ID: 3891306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of acebutolol, a new beta-receptor antagonist on heart rate and rate-pressure product in normal subjects.
    Sharma PL
    Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):290-7. PubMed ID: 1002366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.